5:06 p.m. ET, March 4, 2021
Massachusetts governor says people over 65 will be vaccine eligible next week
From CNN’s Alec Snyder
Massachusetts Gov. Charlie Baker speaks during a press briefing in Lawrence, Massachusetts, on March 4.
Pool/WHDH
Massachusetts Gov. Charlie Baker announced that the state anticipates administering 250,000 doses of the Covid-19 vaccine next week, which would be consistent with the current week’s projections.
He said 300,000 to 400,000 new state residents will be eligible for vaccinations next week: those over 65 — down from the age 75 restriction in Massachusetts — and those with two or more high-risk medical conditions.
However, Baker said 150,000 of its available doses next week are first doses, meaning a large swath of those eligible will not immediately receive a vaccine.
Baker also said the state is not expecting a change for the remainder of March to its rate of roughly 150,000 first doses available per week.
Fenway Park, the home of the Boston Red Sox, will also transition away from its status as a mass vaccination site due to the forthcoming Major League Baseball season, Baker said. The last day Fenway Park will accept appointments is March 27, and first doses received at Fenway before its closure will be accepted at the Hynes Convention Center, where the Fenway operations will relocate. Hynes’ own vaccinations will accept appointments beginning March 18, Baker said.
Massachusetts’ Covid-19 case and vaccination data Thursday showed 1,553 new cases of the virus identified and 755 people currently hospitalized for the virus, Baker said. The state has administered 1.8 million vaccines, 1.2 million of which are first doses. Of those vaccinated, 70% of recipients are age 75 and over, and Baker said Massachusetts is second in the nation in its percentage of Black residents receiving at least one dose.
Note: These numbers were released by the Massachusetts Department of Public Health and may not line up exactly in real time with CNN’s database drawn from the US Centers for Disease Control and Prevention, Johns Hopkins University and The COVID Tracking Project.